Derived neutrophil-to lymphocyte ratio (dNLR) change between baseline and cycle 2 is correlated with benefit during immune checkpoint inhibitors (ICI) in advanced non-small cell lung cancer (NSCLC) patients Meeting Abstract
| Authors: | Mezquita, L.; Arbour, K.; Auclin, E.; Saravia, D.; Rizvi, H.; Hendriks, L.; Planchard, D.; Park, W.; Nadal, E.; Ruffinelli Rodriguez, J. C.; Ponce, S.; Audigier-Valette, C.; Marilniello, A. P.; Zalcman, G.; Majem, M.; Schiavone, G.; Dingemans, A. M. C.; Lopes, G.; Hellmann, M. D.; Besse, B. |
| Abstract Title: | Derived neutrophil-to lymphocyte ratio (dNLR) change between baseline and cycle 2 is correlated with benefit during immune checkpoint inhibitors (ICI) in advanced non-small cell lung cancer (NSCLC) patients |
| Meeting Title: | 43rd ESMO Congress (ESMO 2018) |
| Journal Title: | Annals of Oncology |
| Volume: | 29 |
| Issue: | Suppl. 8 |
| Meeting Dates: | 2018 Oct 19-23 |
| Meeting Location: | Munich, Germany |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2018-10-01 |
| Start Page: | mdy292.029 |
| Language: | English |
| ACCESSION: | WOS:000459277303177 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdy292.029 |
| Notes: | Meeting Abstract: 1407P -- Appears on page viii508 of the abstract book -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
